Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,600 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 November 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 216 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 38 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is N  [Clear All Filters]
2020
C. J. Taylor, Ordonez-Mena, J. M., Jones, N. R., Roalfe, A. K., Lay-Flurrie, S., Marshall, T., and Hobbs, F. D. R., “National trends in heart failure mortality in men and women, United Kingdom, 2000-2017”, Eur J Heart Fail, 2020.
C. J. Sammon, Leahy, T. P., and Ramagopalan, S., “Nonindependence of patient data in the clinical practice research datalink: a case study in atrial fibrillation patients”, J Comp Eff Res, 2020.
2019
A. D. Shah, Bailey, E., Williams, T., Denaxas, S., Dobson, R., and Hemingway, H., “Natural language processing for disease phenotyping in UK primary care records for research: a pilot study in myocardial infarction and death”, J Biomed Semantics, vol. 10, p. 20, 2019.
J. M. Ryan, Peterson, M. D., Matthews, A., Ryan, N., Smith, K. J., O'Connell, N. E., Liverani, S., Anokye, N., Victor, C., and Allen, E., “Noncommunicable disease among adults with cerebral palsy: A matched cohort study”, Neurology, 2019.
2018
K. J. Rothnie, Mullerova, H., Smeeth, L., and Quint, J. K., “Natural History of Chronic Obstructive Pulmonary Disease Exacerbations in a General Practice-based Population with Chronic Obstructive Pulmonary Disease”, Am J Respir Crit Care Med, vol. 198, pp. 464-471, 2018.
E. L. Axson, Bloom, C. I., and Quint, J. K., “Nontuberculous mycobacterial disease managed within UK primary care, 2006-2016”, Eur J Clin Microbiol Infect Dis, vol. 37, pp. 1795-1803, 2018.
F. A. Pearce, Lanyon, P. C., Watts, R. A., Grainge, M. J., Abhishek, A., and Hubbard, R. B., “Novel insights into the aetiology of granulomatosis with polyangiitis-a case-control study using the Clinical Practice Research Datalink”, Rheumatology (Oxford), vol. 57, pp. 1002-1010, 2018.
2017
D. C. Perry, Metcalfe, D., Costa, M. L., and Van Staa, T., “A nationwide cohort study of slipped capital femoral epiphysis”, Arch Dis Child, vol. 102, pp. 1132-1136, 2017.
2016
C. Windsor, Herrett, E., Smeeth, L., and Quint, J. K., “No association between exacerbation frequency and stroke in patients with COPD”, Int J Chron Obstruct Pulmon Dis, vol. 11, pp. 217-25, 2016.
T. Wilke, Mueller, S., Groth, A., Berg, B., Fuchs, A., Sikirica, M., Logie, J., Martin, A., and Maywald, U., “Non-Persistence and Non-Adherence of Patients with Type 2 Diabetes Mellitus in Therapy with GLP-1 Receptor Agonists: A Retrospective Analysis”, Diabetes Ther, vol. 7, pp. 105-24, 2016.
E. Berni, Scott, L. A., Jenkins-Jones, S., de Voogd, H., Rocha, M. S., Butler, C. C., Morgan, C. L., and Currie, C. J., “Non-Response to Antibiotic Treatment in Adolescents for Four Common Infections in UK Primary Care 1991-2012: A Retrospective, Longitudinal Study”, Antibiotics (Basel), vol. 5, 2016.
2015
C. Becker, Jick, S. S., Meier, C. R., and Bodmer, M., “No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study”, BMC Cancer, vol. 15, p. 719, 2015.
C. Becker, Wilson, J. C., Jick, S. S., and Meier, C. R., “Non-steroidal anti-inflammatory drugs and the risk of head and neck cancer: A case-control analysis”, Int J Cancer, vol. 137, pp. 2424-31, 2015.
D. Reinau, Surber, C., Jick, S. S., and Meier, C. R., “Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer”, Int J Cancer, vol. 137, pp. 144-53, 2015.
2014
H. I. McDonald, Nitsch, D., Millett, E. R., Sinclair, A., and Thomas, S. L., “New estimates of the burden of acute community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using linked electronic health records”, Diabet Med, vol. 31, pp. 606-14, 2014.
S. J. Price, Shephard, E. A., Stapley, S. A., Barraclough, K., and Hamilton, W. T., “Non-visible versus visible haematuria and bladder cancer risk: a study of electronic records in primary care”, Br J Gen Pract, vol. 64, pp. e584-9, 2014.
2013
F. J. Bannon, O'Rorke, M. A., Murray, L. J., Hughes, C. M., Gavin, A. T., Fleming, S. J., and Cardwell, C. R., “Non-steroidal anti-inflammatory drug use and brain tumour risk: a case-control study within the Clinical Practice Research Datalink”, Cancer Causes Control, vol. 24, pp. 2027-34, 2013.
J. C. Wilson, O'Rorke, M. A., Cooper, J. A., Murray, L. J., Hughes, C. M., Gormley, G. J., and Anderson, L. A., “Non-steroidal anti-inflammatory drug use and cervical cancer risk: a case-control study using the Clinical Practice Research Datalink”, Cancer Epidemiol, vol. 37, pp. 897-904, 2013.
2012
H. Mullerova, Chigbo, C., Hagan, G. W., Woodhead, M. A., Miravitlles, M., Davis, K. J., and Wedzicha, J. A., “The natural history of community-acquired pneumonia in COPD patients: a population database analysis”, Respir Med, vol. 106, pp. 1124-33, 2012.
L. Azoulay, Dell'Aniello, S., Simon, T. A., Langleben, D., Renoux, C., and Suissa, S., “A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case-control study”, BMC Cardiovasc Disord, vol. 12, p. 49, 2012.
D. Suissa, Delaney, J. A., Dial, S., and Brassard, P., “Non-steroidal anti-inflammatory drugs and the risk of Clostridium difficile-associated disease”, Br J Clin Pharmacol, vol. 74, pp. 370-5, 2012.
2011
M. T. Osterman, Yang, Y. X., Brensinger, C., Forde, K. A., Lichtenstein, G. R., and Lewis, J. D., “No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease”, Clin Gastroenterol Hepatol, vol. 9, pp. 875-80, 2011.
C. Becker, Jick, S. S., and Meier, C. R., “NSAID use and risk of Parkinson disease: a population-based case-control study”, Eur J Neurol, vol. 18, pp. 1336-42, 2011.
2010
M. C. Bradley, Hughes, C. M., Cantwell, M. M., Napolitano, G., and Murray, L. J., “Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case-control study”, Br J Cancer, vol. 102, pp. 1415-21, 2010.
2008
C. R. Cardwell, Carson, D. J., and Patterson, C. C., “No association between routinely recorded infections in early life and subsequent risk of childhood-onset Type 1 diabetes: a matched case-control study using the UK General Practice Research Database”, Diabet Med, vol. 25, pp. 261-7, 2008.
Y. Mikaeloff, Kezouh, A., and Suissa, S., “Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease”, Br J Clin Pharmacol, vol. 65, pp. 203-9, 2008.
2006
R. A. Hughes, Charlton, J., Latinovic, R., and Gulliford, M. C., “No association between immunization and Guillain-Barre syndrome in the United Kingdom, 1992 to 2000”, Arch Intern Med, vol. 166, pp. 1301-4, 2006.
H. Jick, Kaye, J. A., Russmann, S., and Jick, S. S., “Nonsteroidal antiinflammatory drugs and acute myocardial infarction in patients with no major risk factors”, Pharmacotherapy, vol. 26, pp. 1379-87, 2006.
C. Huerta, Varas-Lorenzo, C., Castellsague, J., and Rodriguez, L. A. Garcia, “Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population”, Heart, vol. 92, pp. 1610-5, 2006.
M. A. Hernan, Logroscino, G., and Rodriguez, L. A. Garcia, “Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease”, Neurology, vol. 66, pp. 1097-9, 2006.
2005
R. Ryan, Newnham, A., Khunti, K., and Majeed, A., “New cases of diabetes mellitus in England and Wales, 1994-1998: database study”, Public Health, vol. 119, pp. 892-9, 2005.
G. M. Clifford, Logie, J., and Farmer, R. D., “No risk of drug-associated liver injury with alpha1-adrenoreceptor blocking agents in men with BPH: results from an observational study using the GPRD”, Pharmacoepidemiol Drug Saf, vol. 14, pp. 75-80, 2005.
C. Huerta, Castellsague, J., Varas-Lorenzo, C., and Rodriguez, L. A. Garcia, “Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population”, Am J Kidney Dis, vol. 45, pp. 531-9, 2005.
2004
A. Ruigomez, Rodriguez, L. A. Garcia, Wallander, M. A., Johansson, S., Graffner, H., and Dent, J., “Natural history of gastro-oesophageal reflux disease diagnosed in general practice”, Aliment Pharmacol Ther, vol. 20, pp. 751-60, 2004.
2003
T. P. van Staa, Boulton, F., Cooper, C., Hagenbeek, A., Inskip, H., and Leufkens, H. G., “Neutropenia and agranulocytosis in England and Wales: incidence and risk factors”, Am J Hematol, vol. 72, pp. 248-54, 2003.
L. A. Garcia Rodriguez and Hernandez-Diaz, S., “Nonsteroidal antiinflammatory drugs as a trigger of clinical heart failure”, Epidemiology, vol. 14, pp. 240-6, 2003.
1993
H. Jick, Derby, L. E., Rodriguez, L. A. Garcia, Jick, S. S., and Dean, A. D., “Nonsteroidal antiinflammatory drugs and certain rare, serious adverse events: a cohort study”, Pharmacotherapy, vol. 13, pp. 212-7, 1993.
1992
S. Mannino, Garcia-Rodriguez, L. A., and Jick, S. S., “NSAIDs, quinolones and convulsions: An epidemiologic approach”, vol. 6, pp. 119-128, 1992.
[Page last reviewed 6 November 2020]